$500 Million is the total value of Bruce & Co., Inc.'s 31 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
UHAL | Sell | Amerco | $54,725,000 | +6.2% | 75,355 | -5.6% | 10.94% | -0.1% |
FPL | Sell | Nextera Energy | $45,783,000 | +16.3% | 490,400 | -2.2% | 9.15% | +9.4% |
ABBV | Abbvie | $41,093,000 | +25.5% | 303,500 | 0.0% | 8.22% | +18.1% | |
VRX | Bausch Health | $38,129,000 | -0.9% | 1,381,000 | 0.0% | 7.62% | -6.7% | |
ALL | Sell | Allstate | $35,212,000 | -7.7% | 299,300 | -0.2% | 7.04% | -13.2% |
PFE | Sell | Pfizer | $32,105,000 | +37.0% | 543,700 | -0.2% | 6.42% | +29.0% |
CMS | CMS Energy | $30,475,000 | +8.9% | 468,500 | 0.0% | 6.09% | +2.5% | |
DUK | Duke Energy | $30,022,000 | +7.5% | 286,200 | 0.0% | 6.00% | +1.2% | |
AAPL | Sell | Apple | $29,725,000 | -13.4% | 167,400 | -31.0% | 5.94% | -18.5% |
XEL | XEL Energy | $27,926,000 | +8.3% | 412,500 | 0.0% | 5.58% | +2.0% | |
ABT | Abbott | $24,995,000 | +19.1% | 177,600 | 0.0% | 5.00% | +12.1% | |
MRK | Merck | $24,808,000 | +2.0% | 323,700 | 0.0% | 4.96% | -4.0% | |
Paratekcv 4.75% | $15,272,000 | +4.5% | 16,600,000 | 0.0% | 3.05% | -1.6% | ||
SUPN | Supernus | $11,725,000 | +9.3% | 402,105 | 0.0% | 2.34% | +2.9% | |
GE | GE | $9,860,000 | -8.3% | 104,375 | 0.0% | 1.97% | -13.7% | |
AVA | Avista | $8,710,000 | +8.6% | 205,000 | 0.0% | 1.74% | +2.2% | |
PRTK | Buy | Paratek | $6,480,000 | -0.7% | 1,443,312 | +7.4% | 1.30% | -6.6% |
SIRI | XM Sirius | $5,447,000 | +4.1% | 857,843 | 0.0% | 1.09% | -2.1% | |
Acorda Theraputicscv 6.0% | $4,075,000 | 0.0% | 5,000,000 | 0.0% | 0.82% | -5.9% | ||
NEM | Newmont | $4,031,000 | +14.2% | 65,000 | 0.0% | 0.81% | +7.5% | |
AMYT | Sell | Amryt | $3,403,000 | -30.9% | 315,182 | -22.6% | 0.68% | -35.0% |
EDAP | EDAP | $3,388,000 | -6.1% | 565,652 | 0.0% | 0.68% | -11.7% | |
FATE | Fate Theraputics | $3,335,000 | -1.3% | 57,000 | 0.0% | 0.67% | -7.1% | |
ASH | Ashland | $2,691,000 | +119.1% | 25,000 | 0.0% | 0.54% | +106.1% | |
MNKD | Mannkind | $1,726,000 | +0.5% | 395,073 | 0.0% | 0.34% | -5.5% | |
IGMS | IGM Bioscience | $1,613,000 | -55.4% | 55,000 | 0.0% | 0.32% | -57.9% | |
OGN | Organon | $985,000 | -7.2% | 32,370 | 0.0% | 0.20% | -12.4% | |
VTRS | Viatris | $832,000 | -0.1% | 61,512 | 0.0% | 0.17% | -6.2% | |
Novavaxcv 3.75% | $828,000 | -20.2% | 600,000 | 0.0% | 0.17% | -24.9% | ||
FTK | Flotek | $476,000 | -10.4% | 421,671 | 0.0% | 0.10% | -15.9% | |
RLI | RLI | $269,000 | +12.1% | 2,400 | 0.0% | 0.05% | +5.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Nextera Energy | 42 | Q3 2023 | 10.4% |
Abbvie | 42 | Q3 2023 | 8.4% |
MERCK & CO INC | 42 | Q3 2023 | 9.7% |
PFIZER INC | 42 | Q3 2023 | 7.2% |
XEL Energy | 42 | Q3 2023 | 6.9% |
EDAP | 42 | Q3 2023 | 1.9% |
RLI CORP | 42 | Q3 2023 | 2.1% |
Uhaul | 41 | Q3 2023 | 22.3% |
Allstate | 41 | Q3 2023 | 8.1% |
Abbott | 41 | Q3 2023 | 5.7% |
View Bruce & Co., Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
EDAP TMS SA | November 16, 2015 | 1,204,980 | 4.8% |
C&D TECHNOLOGIES INC | January 06, 2011 | 58,122,789 | 11.0% |
ASTROTECH Corp \WA\ | January 26, 2010 | 1,120,073 | 6.8% |
VION PHARMACEUTICALS INC | March 13, 2009 | 781,017 | 9.0% |
AMERICA SERVICE GROUP INC /DE | February 10, 2009 | 665,617 | 7.3% |
ALANCO TECHNOLOGIES INC | February 13, 2008 | 1,681,706 | 7.4% |
SPACEHAB INC \WA\ | February 13, 2008 | 1,344,073 | 9.9% |
View Bruce & Co., Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-15 |
13F-HR | 2022-11-15 |
13F-HR | 2022-08-09 |
13F-HR | 2022-05-11 |
13F-HR | 2022-02-16 |
13F-HR | 2021-11-12 |
View Bruce & Co., Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.